JUPITER NEUROSCIENCES, INC. Accrued Professional Fees
JUPITER NEUROSCIENCES, INC. (JUNS) had Accrued Professional Fees of $493.92 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Accrued Liabilities
us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent · last filed 2026-08-14
- 2026-06-30: Accrued Professional Fees $493.92K.
- 2026-03-31: Accrued Professional Fees $338.90K.
- 2025-12-31: Accrued Professional Fees $467.17K.
- 2025-09-30: Accrued Professional Fees $45.51K.
| Period end | Accrued Professional Fees |
|---|---|
| 2026-06-30 | $493.92K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $338.90K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $467.17K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $45.51K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $70.89K 10-Q · filed 2025-08-19 |
| 2025-03-31 | $103.59K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $40.27K 10-K · filed 2026-04-01 |
| 2024-09-30 | $219.93K 10-Q · filed 2024-12-23 |
| 2023-12-31 | $174.05K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |